Not yet recruitingNAINTERVENTIONAL

A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems

This study is testing a product called AP-Brain to see how well it works and if it's safe for healthy young adults, aged 18-39, who feel they have attention difficulties. The main goal is to find out if AP-Brain, taken at different strengths (1g, 3g, or 5g), can improve their brain function and focus compared to a dummy pill (placebo). Participants will take either AP-Brain or a placebo and complete tests to assess their memory and attention over a period of time. We want to understand what dose might be most effective in helping with attention problems.

At a glance

Status

Not yet recruiting

Phase

Sponsor

Rousselot BVBA

Enrolment target

120

Start

01 May 2026

Estimated completion

01 Oct 2026

Cognition Cognitive Function

What is this study about?

This research study is looking into a new product called AP-Brain. We want to find out two main things: first, if it's safe to use, and second, if it can help improve how well healthy young adults think, focus, and remember things. We are particularly interested in people aged 18 to 39 who feel they have problems with their attention.

To do this, we'll be giving some participants AP-Brain at different strengths (1 gram, 3 grams, or 5 grams) and others a 'dummy pill', called a placebo, which looks the same but contains no active ingredient. This helps us see if any changes are truly due to AP-Brain. Over about 56 days, we'll watch carefully to see if there are any differences in their thinking skills, especially their attention, when measured through special tests.

The information we gather from this study will help us understand if AP-Brain could be a helpful option for young adults who experience difficulties with their attention, and if so, what strength might be best. It's an important step in learning more about how we can support brain function and focus.

Key takeaways

This study investigates different doses of AP-Brain for attention problems.
It's for healthy adults aged 18-39 who self-report attention difficulties.
Participants will receive AP-Brain or a placebo over 8 weeks.
The main goal is to check safety and how AP-Brain affects thinking skills.
Your attention and memory will be assessed through specific tests.
Participation helps advance understanding of attention support.

Who may be eligible?

This study is looking for healthy men and women between the ages of 18 and 39. A key requirement is that you feel you have problems with your attention or focus, which will be checked using a special questionnaire.

If you are a woman who could become pregnant, you'll need to have a negative pregnancy test and agree to use effective birth control throughout the study. This includes methods like the pill, patches, or other long-term options. If you've had certain medical procedures like a hysterectomy or have been through menopause for at least a year, these rules may not apply to you.

There are also some lifestyle agreements you'll need to follow before and during clinic visits, such as avoiding high levels of caffeine, certain pain relievers (like ibuprofen), alcohol, certain allergy medicines, and intense exercise for a short period before appointments. You'll also need to try and keep your usual habits regarding diet, exercise, and sleep as consistent as possible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 18 and 39 years old?
Do you feel you have problems with your attention or focus?
If you are a woman, are you unable to become pregnant, or willing to use effective birth control during the study?
Are you able to agree to follow certain lifestyle guidelines (e.g., avoiding high caffeine, certain medications) around clinic visits?
Are you generally in good health?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you will be asked to attend several clinic visits over approximately eight weeks. At these visits, you will undergo tests to check your memory and attention, likely involving questionnaires or computer-based tasks. You will be given either AP-Brain (at a dose of 1g, 3g, or 5g) or a placebo to take daily throughout the study period. You'll be asked to consume the study product as instructed and complete these assessment questionnaires at regular intervals. Your overall health and any potential side effects will be monitored closely by the study team during these visits.

Potential risks and benefits

Taking part in a study like this means you'll be helping researchers learn more about how AP-Brain might affect attention. While there's no guarantee that you will personally benefit, the information gained could help others in the future. As with any medication, there's always a possibility of side effects, although the study will closely monitor your health for any issues. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

KGK Science Inc.
Verified postcode
London, Canada

Common questions

What is AP-Brain?

AP-Brain is the product being tested in this study to see if it can help improve attention and brain function.

What is a placebo?

A placebo is a 'dummy pill' that looks exactly like the study product but contains no active ingredients. It helps us compare the effects of AP-Brain accurately.

How long will the study last?

The study involves taking the product and attending clinic visits for approximately 56 days (about eight weeks).

Will I know if I'm taking AP-Brain or the placebo?

No, you won't know if you're receiving AP-Brain or the placebo. This is to ensure the results are unbiased and accurate.

Are there any costs involved in participating?

The study should not involve any costs to you, and typically, research studies cover expenses related to your participation.

How to find out more

Marc Moulin, PhD

mmoulin@kgkscience.com 2267819094 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.